Her company, Biobot Analytics, is analyzing wastewater to give communities the information they need for the battle

Nanotech pioneer aims to pursue grand challenges rather than just write about them

Dozens of women lead CRISPR-based projects worldwide. Here are a few who've built start-ups around the technology

With guest editor Jennifer Doudna, CRISPR pioneer

Our collection of chemistry photos will help train an algorithm to recognize lab materials, vessels, and processes

C&EN looks at how scientists are adapting to travel restrictions and working from home

DRT brings sustainable fragrance ingredients and industrial additives

C&EN looks at how scientists are working from home and adapting to travel restrictions

USDA delays some requirements for growers; FDA seeks more data on cannabidiol products

Peru seeks to keep rudimentary gold refining from exposing communities to neurotoxic metal

The past 10 years have been great for US ethylene producers, but they doubt a repeat performance

Scientists explore how to revamp the hair-thin silica glass fibers to transmit more and more data

Specialty chemical CEOs are rolling with the punches to keep their firms going

Lower ozone levels led to higher grape and almond yields-and decarbonizing the state's economy could provide a further boost

Chemical makers and oil producers are pulling back on production, reconsidering investments

Amid university shutdowns worldwide, professors and students adjust what social distancing means for lab scientists

Large, disordered pores allow the gel to capture soil without damaging pigments

They persist in the pharma business, even as chemical companies in the West have mostly exited

Chemical educator and <i>Compound Interest</i> blogger Andy Brunning digs into how plant fertilizers make use of the periodic table.

Industry is deemed essential critical infrastructure by federal and state governments

Italian workers threaten to strike, but German, UK companies and workers pull together

Old anti-malarial drugs have shown mixed results in the small clinical trials conducted so far

The nucleoside inhibitor has advantages over Gilead's remdesivir but has yet to be tested in humans

Gilead Sciences' antiviral is in multiple late-stage trials to treat coronavirus infections. Don't expect a home run, say infectious disease experts

Chemically distinct regions of alloys can help create strong yet flexible nanostructured metals

Technology could lessen the environmental impact of 3-D printed buildings by adapting locally harvested soils

Activists say broad lack of enforcement threatens safety

Lingering logistic problems and a sputtering economy mean hard times for companies

Resources are freely available through April 17

C&EN advice columnist offers 4 tips on adapting to times of uncertainty

Lingering logistic problems and a sputtering economy mean hard times for companies

Editors in Europe and the US plan to work with authors whose lives and labs have been disrupted by the novel coronavirus

Chemours plans to appeal the decision to Delaware's Supreme Court